Early research (Phase 1)Study completedNCT02491281
What this trial is testing
First-in-human Single Ascending Dose Study of LNA043 in Patients Scheduled for Total Knee Replacement
Who this might be right for
Primary Osteoarthritis Patients Scheduled for Total Knee Replacement Surgery
Novartis Pharmaceuticals 28